International Biotechnology (LON:IBT) Share Price Passes Above 200 Day Moving Average – Here’s Why

Shares of International Biotechnology (LON:IBT) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 959.39 and traded as high as GBX 1,214.25. International Biotechnology shares last traded at GBX 1,205, with a volume of 151,650 shares trading hands.

International Biotechnology Stock Performance

The stock has a market cap of £359.66 million, a price-to-earnings ratio of 4.67 and a beta of 0.52. The company’s fifty day simple moving average is GBX 1,010.01 and its two-hundred day simple moving average is GBX 962.11. The company has a debt-to-equity ratio of 9.43, a current ratio of 0.11 and a quick ratio of 0.32.

International Biotechnology (LON:IBT) last issued its quarterly earnings data on Tuesday, May 12th. The company reported GBX (4.83) earnings per share (EPS) for the quarter. The business had revenue of GBX 24 million for the quarter. International Biotechnology had a net margin of 82.27% and a return on equity of 27.35%. On average, analysts forecast that International Biotechnology will post 0.9435943 earnings per share for the current year.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.